This problem can be solved by CRP apheresis, which removes CRP from the blood plasma after myocardial infarction, significantly reducing the infarct area and improving LVEF (Ries et al., 2018, 2019; Mattecka et al., 2019). This evidence concerns the gene CRP and myocardial infarction.